Xiao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao Xu has a total of 203 co-authors. Here are the top co-authors by number of shared publications:
- Jason Dennis Wright
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
18 shared publications - Ling Chen
Columbia University College of Physicians and Surgeons, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York, NY, USA
15 shared publications - Jennifer S. Ferris
Columbia University College of Physicians and Surgeons, New York, NY, USA; Columbia University, Joseph L. Mailman School of Public Health, New York, NY, USA
14 shared publications - Kevin J. Rouse
Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York
14 shared publications - Brandy M. Heckman-Stoddard
National Cancer Institute 10 Rockville, MD
13 shared publications - Chung Yin Kong
Division of General Internal Medicine Icahn School of Medicine at Mount Sinai New York New York USA
13 shared publications
Latest Publications
- 16 September 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
Methods for Development of AAGL Clinical Practice Guidelines
- 16 September 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
Methods for Development of AAGL Clinical Practice Guidelines
- Open Access
Congenital heart disease in pregnancy and severe maternal morbidity: A distributed data network study
Introduction: Pregnant people with congenital heart disease (CHD) are a growing patient population in obstetrics, yet evidence on the risk for severe maternal morbidity (SMM) has largely been limited to studies that lack specificity for CHD. We conducted this study to demonstrate the utility of distributed data networks for obstetric research and to characterize pregnant patients with CHD and their risk of SMM. Methods: The study included female patients aged 12–55 years who delivered between 2015 and 2026 at three US academic healthcare organizations. We used a distributed data network study design by developing analytical code, executing the code locally at each organization using its electronic health record (EHR) data in a common data model (CDM), then aggregating the results. This analytical approach is rigorous, is reproducible, and protects patient confidentiality by not sharing patient‐level data. The Observational Medical Outcomes Partnership (OMOP) CDM was used by each organization, and we used OMOP standard concepts to identify CHD and SMM. We categorized outcomes as SMM, non‐transfusion SMM, and cardiac SMM based on the CDC SMM index. We analyzed the incidence of the outcomes and estimated risk ratios (RRs) and Wald 95% confidence intervals (CIs) using contingency tables. Results: The prevalence of CHD in pregnancy was 2.20% among 166,033 deliveries across three healthcare organizations. A total of 19.30% of people with CHD had an acquired heart condition, compared to 2.14% of people without CHD. SMM occurred in 9.43% of deliveries to people with CHD compared to 4.53% among people without CHD (RR, 2.08; 95% CI, 1.88, 2.31), and non‐transfusion SMM occurred in 6.72% vs 2.55% of deliveries (RR, 2.63; 95% CI, 2.33, 2.98), respectively. Cardiac SMM represented 51.84% of non‐transfusion SMM among people with CHD compared to 16.18% among people without CHD. Conclusions: Our distributed data network study using EHR data from three geographically diverse US healthcare organizations found that one in 15 people with CHD had non‐transfusion SMM compared with one in 39 people without CHD. This study demonstrates the feasibility and utility of distributed data networks for obstetric research and provides novel evidence on maternal outcomes for pregnant patients with CHD.
Open AccessCongenital heart disease in pregnancy and severe maternal morbidity: A distributed data network study
Introduction: Pregnant people with congenital heart disease (CHD) are a growing patient population in obstetrics, yet evidence on the risk for severe maternal morbidity (SMM) has largely been limited to studies that lack specificity for CHD. We conducted this study to demonstrate the utility of distributed data networks for obstetric research and to characterize pregnant patients with CHD and their risk of SMM. Methods: The study included female patients aged 12–55 years who delivered between 2015 and 2026 at three US academic healthcare organizations. We used a distributed data network study design by developing analytical code, executing the code locally at each organization using its electronic health record (EHR) data in a common data model (CDM), then aggregating the results. This analytical approach is rigorous, is reproducible, and protects patient confidentiality by not sharing patient‐level data. The Observational Medical Outcomes Partnership (OMOP) CDM was used by each organization, and we used OMOP standard concepts to identify CHD and SMM. We categorized outcomes as SMM, non‐transfusion SMM, and cardiac SMM based on the CDC SMM index. We analyzed the incidence of the outcomes and estimated risk ratios (RRs) and Wald 95% confidence intervals (CIs) using contingency tables. Results: The prevalence of CHD in pregnancy was 2.20% among 166,033 deliveries across three healthcare organizations. A total of 19.30% of people with CHD had an acquired heart condition, compared to 2.14% of people without CHD. SMM occurred in 9.43% of deliveries to people with CHD compared to 4.53% among people without CHD (RR, 2.08; 95% CI, 1.88, 2.31), and non‐transfusion SMM occurred in 6.72% vs 2.55% of deliveries (RR, 2.63; 95% CI, 2.33, 2.98), respectively. Cardiac SMM represented 51.84% of non‐transfusion SMM among people with CHD compared to 16.18% among people without CHD. Conclusions: Our distributed data network study using EHR data from three geographically diverse US healthcare organizations found that one in 15 people with CHD had non‐transfusion SMM compared with one in 39 people without CHD. This study demonstrates the feasibility and utility of distributed data networks for obstetric research and provides novel evidence on maternal outcomes for pregnant patients with CHD.
- Open Access
- 31 October 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (1) , 102769
Physician-level variability in adopting opportunistic salpingectomy for ovarian cancer prevention at the time of hysterectomy
- 31 October 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (1) , 102769
Open AccessPhysician-level variability in adopting opportunistic salpingectomy for ovarian cancer prevention at the time of hysterectomy
- 23 September 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 35 (12) , 102676
Use and outcomes of hormonal therapy for advanced-stage, low-grade serous ovarian cancer
- 23 September 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 35 (12) , 102676
Use and outcomes of hormonal therapy for advanced-stage, low-grade serous ovarian cancer
- 1 September 2025
- Published by Elsevier in Women's Health Issues
- Vol. 35 (5) , 306-313
Diagnostic Evaluation for Abnormal Uterine Bleeding at Emergency Departments in the United States
- 1 September 2025
- Published by Elsevier in Women's Health Issues
- Vol. 35 (5) , 306-313
Diagnostic Evaluation for Abnormal Uterine Bleeding at Emergency Departments in the United States
- 29 August 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (4) , 473-474
Author’s Reply to “Regarding: Evidence-Based Practice for Minimization of Blood Loss During Laparoscopic Myomectomy: An AAGL Practice Guideline”
- 29 August 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 33 (4) , 473-474
Author’s Reply to “Regarding: Evidence-Based Practice for Minimization of Blood Loss During Laparoscopic Myomectomy: An AAGL Practice Guideline”
- Open Access
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Table 5 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
Supplemental Table 5: Objective function inputs.
- 1 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 5 from Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States
Supplemental Table 5: Objective function inputs.